Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2005 4
2006 1
2007 8
2008 7
2009 6
2010 6
2011 4
2012 6
2013 6
2014 3
2015 8
2016 9
2017 11
2018 10
2019 7
2020 18
2021 15
2022 7
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.
Nair P, Wenzel S, Rabe KF, Bourdin A, Lugogo NL, Kuna P, Barker P, Sproule S, Ponnarambil S, Goldman M; ZONDA Trial Investigators. Nair P, et al. N Engl J Med. 2017 Jun 22;376(25):2448-2458. doi: 10.1056/NEJMoa1703501. Epub 2017 May 22. N Engl J Med. 2017. PMID: 28530840 Free article. Clinical Trial.
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy.
Louis R, Harrison TW, Chanez P, Menzella F, Philteos G, Cosio BG, Lugogo NL, de Luiz G, Burden A, Adlington T, Keeling N, Kwiatek J, Garcia Gil E; ANDHI Study Investigators. Louis R, et al. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1759-1770.e7. doi: 10.1016/j.jaip.2023.03.009. Epub 2023 Mar 21. J Allergy Clin Immunol Pract. 2023. PMID: 36948488 Free article.
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
Techniques of endoscopic airway tumor treatment.
Guibert N, Mhanna L, Droneau S, Plat G, Didier A, Mazieres J, Hermant C. Guibert N, et al. Among authors: didier a. J Thorac Dis. 2016 Nov;8(11):3343-3360. doi: 10.21037/jtd.2016.11.49. J Thorac Dis. 2016. PMID: 28066616 Free PMC article. Review.
[Severe asthma revisited by biologic therapies emergences].
Guilleminault L, Didier A. Guilleminault L, et al. Among authors: didier a. Presse Med. 2019 Mar;48(3 Pt 1):310-321. doi: 10.1016/j.lpm.2019.03.001. Epub 2019 Mar 26. Presse Med. 2019. PMID: 30922670 Review. French.
Specific immunotherapy in grass pollen allergy.
Mailhol C, Didier A. Mailhol C, et al. Among authors: didier a. Hum Vaccin Immunother. 2012 Oct;8(10):1544-7. doi: 10.4161/hv.22357. Epub 2012 Oct 1. Hum Vaccin Immunother. 2012. PMID: 23095875 Free PMC article. Review.
How can we minimise the use of regular oral corticosteroids in asthma?
Bourdin A, Adcock I, Berger P, Bonniaud P, Chanson P, Chenivesse C, de Blic J, Deschildre A, Devillier P, Devouassoux G, Didier A, Garcia G, Magnan A, Martinat Y, Perez T, Roche N, Taillé C, Val P, Chanez P. Bourdin A, et al. Among authors: didier a. Eur Respir Rev. 2020 Feb 5;29(155):190085. doi: 10.1183/16000617.0085-2019. Print 2020 Mar 31. Eur Respir Rev. 2020. PMID: 32024721 Free PMC article. Review.
123 results